Literature DB >> 10721996

The evolving role of combined modality therapy in head and neck cancer.

K T Robbins1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10721996     DOI： 10.1001/archotol.126.3.265

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


× No keyword cloud information.
  6 in total

1.  Intra-arterial high-dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer.

Authors:  S Rohde; A F Kovács; B Turowski; B Yan; F Zanella; J Berkefeld
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Reliability of CT-based tumor volumetry after intraarterial chemotherapy in patients with small carcinoma of the oral cavity and the oropharynx.

Authors:  Stefan Rohde; Adorján F Kovács; Joachim Berkefeld; Bernd Turowski
Journal:  Neuroradiology       Date:  2006-04-12       Impact factor: 2.804

3.  [Local chemotherapy for squamous cell cancer of the oral cavity and oropharynx].

Authors:  S Rohde; A F Kovács; F E Zanella; J Berkefeld; B Turowski
Journal:  Radiologe       Date:  2005-09       Impact factor: 0.635

4.  A novel approach to translymphatic chemotherapy targeting sentinel lymph nodes of patients with oral cancer using intra-arterial chemotherapy - preliminary study.

Authors:  Junkichi Yokoyama; Shin Ito; Shinichi Ohba; Mitsuhisa Fujimaki; Katsuhisa Ikeda
Journal:  Head Neck Oncol       Date:  2011-09-19

5.  Computational fluid dynamics study of intra-arterial chemotherapy for oral cancer.

Authors:  Hiroaki Kitajima; Marie Oshima; Toshinori Iwai; Yoshihito Ohhara; Yasuharu Yajima; Kenji Mitsudo; Iwai Tohnai
Journal:  Biomed Eng Online       Date:  2017-05-15       Impact factor: 2.819

6.  Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.

Authors:  A Homma; T Sakashita; D Yoshida; R Onimaru; K Tsuchiya; F Suzuki; K Yasuda; H Hatakeyama; J Furusawa; T Mizumachi; S Kano; N Inamura; S Taki; H Shirato; S Fukuda
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.